证券代码：301108 证券简称：洁雅股份 公告编号：2025-077 铜陵洁雅生物科技股份有限公司 2025年半年度分红派息实施公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 铜陵洁雅生物科技股份有限公司（以下简称"公司"）2025 年半年度权益分 派方案已获 2025 年 9 月 15 日召开的 2025 年第五次临时股东会审议通过，现将权 益分派事宜公告如下： 一、股东会审议通过利润分配方案等情况 1、公司于 2025 年 9 月 15 日召开 2025 年第五次临时股东会，审议通过了《关 于 2025 年半年度利润分配方案的议案》。公司 2025 年半年度利润分配方案为： 公司以截至公告日的总股本 112,556,252 股为基数，拟向全体股东每 10 股派发现 金红利 1.00 元（含税），合计派发现金红利 11,255,625.20 元人民币（含税）。本 次利润分配不进行资本公积转增股本，不送红股，剩余未分配利润滚存至下一年 度，用于支持公司经营发展。 2、本次分配方案披露至实施期间，公司股本总额未发生变化。 3、本次实施的分配方案与股东会审 ...

Market Overview - The personal care products sector experienced a significant increase of 28.19% on September 17, with Beijia leading the gains [1] - The Shanghai Composite Index closed at 3876.34, up 0.37%, while the Shenzhen Component Index closed at 13215.46, up 1.16% [1] Stock Performance - Beijia (603059) closed at 32.96, with a rise of 2.33% and a trading volume of 52,600 shares, resulting in a transaction value of 173 million yuan [1] - Baiya Co. (003006) closed at 29.20, up 1.81%, with a trading volume of 30,300 shares and a transaction value of 88.45 million yuan [1] - Dengkang Oral (001328) closed at 40.62, increasing by 1.32%, with a trading volume of 23,600 shares and a transaction value of 96.33 million yuan [1] - Zhongshun Jierou (002511) closed at 8.48, up 0.71%, with a trading volume of 136,300 shares and a transaction value of 115 million yuan [1] - Stable Medical (300888) closed at 39.74, with a slight increase of 0.23%, trading 78,700 shares for a total value of 316 million yuan [1] Capital Flow - The personal care products sector saw a net outflow of 8.42 million yuan from institutional investors and 13.61 million yuan from speculative funds, while retail investors contributed a net inflow of 22.03 million yuan [2] - The capital flow data indicates that the sector is experiencing mixed investor sentiment, with institutional and speculative funds withdrawing while retail investors are increasing their positions [2][3] Individual Stock Capital Flow - For Yanjing Co. (300658), there was a net inflow of 27.24 million yuan from institutional investors, while speculative funds saw a net outflow of 14.17 million yuan [3] - Beijia (603059) had a net inflow of 4.35 million yuan from institutional investors, with speculative funds contributing a net inflow of 10.65 million yuan [3] - Dengkang Oral (001328) experienced a net inflow of 1.30 million yuan from institutional investors, while retail investors contributed a net inflow of 2.24 million yuan [3]

Group 1 - The core viewpoint of the news is that Jeya Co., Ltd. has shown significant trading activity and financial performance, with a notable increase in stock price and financing activities [1][2] - On September 15, Jeya Co., Ltd. experienced a stock price increase of 3.95%, with a trading volume of 134 million yuan [1] - The financing buy-in amount on the same day was 17.33 million yuan, while the financing repayment was 17.05 million yuan, resulting in a net financing buy of 283,100 yuan [1] Group 2 - As of September 15, the total financing and securities balance for Jeya Co., Ltd. was 45.90 million yuan, accounting for 1.16% of the circulating market value, indicating a high level compared to the past year [1] - The company’s main business revenue composition includes wet wipes at 84.62%, facial masks at 11.95%, and personal care products at 1.86% [1] - For the first half of 2025, Jeya Co., Ltd. achieved an operating income of 310 million yuan, representing a year-on-year growth of 8.79%, and a net profit attributable to shareholders of 32.58 million yuan, up 22.55% year-on-year [2]

证券代码：301108 证券简称：洁雅股份 公告编号：2025-076 铜陵洁雅生物科技股份有限公司 2025年第五次临时股东会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1. 本次股东会未出现否决议案的情形。 2. 本次股东会不涉及变更以往股东会已通过的决议。 一、会议召开情况 1、会议召开时间 （1）现场会议召开时间：2025 年 9 月 15 日（星期一）14:30。 （2）网络投票时间：2025 年 9 月 15 日（星期一）。 其中，通过深圳证券交易所交易系统进行网络投票的具体时间为 2025 年 9 月 15 日 9:15-9:25，9:30-11:30，13:00-15:00；通过深圳证券交易所互联网投 票系统（http://wltp.cninfo.com.cn）投票的时间为 2025 年 9 月 15 日 9:15 至 15:00 期间的任意时间。 2、会议召开地点：安徽省铜陵市狮子山经济开发区铜井东路 1928 号铜陵洁 雅生物科技股份有限公司会议室。 3、会议召开方式：本次股东会采用现场表决与网络投票相结合的方式召 ...

天禾律师 股东会法律意见书 安徽天禾律师事务所 关于铜陵洁雅生物科技股份有限公司 2025 年第五次临时股东会法律意见书 天律意 2025 第 02493 号 致：铜陵洁雅生物科技股份有限公司 根据《中华人民共和国公司法》（下称"《公司法》"）、《中华人民共和 国证券法》（下称"《证券法》"）、中国证券监督管理委员会《上市公司股东 会规则》（下称"《股东会规则》"）以及《铜陵洁雅生物科技股份有限公司章 程》（下称"《公司章程》"）的有关规定，安徽天禾律师事务所接受铜陵洁雅 生物科技股份有限公司（下称"公司"）委托，指派冉合庆、杨春波律师（下称 "天禾律师"）出席公司 2025 年第五次临时股东会（下称"本次股东会"）， 并对本次股东会相关事项进行见证，出具法律意见。 本法律意见书是天禾律师根据对本次股东会事实的了解及对我国现行法律、 法规和规范性文件的理解而出具的。 天禾律师同意将本法律意见书作为本次股东会的法定必备文件予以公告，并 依法对所出具的法律意见书承担责任。 天禾律师根据《证券法》相关规定的要求，按照律师行业公认的业务标准、 道德规范和勤勉尽责精神，对本次股东会的召集、召开、与会人员资格、表决程 序 ...

Group 1: Company Performance and Strategy - The company reported Q1 2025 revenue of 124 million CNY and a net profit of 10.06 million CNY, indicating a focus on improving production capacity utilization [3] - The company aims to achieve a production capacity utilization rate of over 80% starting from Q2 2025, with current main production lines operating at full capacity [3] - The company is actively expanding its international brand client base while maintaining a focus on OEM services [3][4] Group 2: Product Development and Market Position - The market share and quarterly growth rate of wet wipes were discussed, with the company currently operating at an 80% capacity utilization rate for wet wipes production [3] - The company is exploring plans to expand the production capacity and product line for wet wipes [3] - There is an ongoing effort to develop proprietary brand business, although the company primarily focuses on OEM production at this stage [3] Group 3: U.S. Operations and Future Outlook - The U.S. factory is in the early stages of setup, including facility renovations and equipment installation, with production expected to commence by mid-2026 [3][4] - The company plans to enhance operational efficiency in the U.S. through automation and optimized management processes [3] - Investors are advised to be cautious due to potential uncertainties related to local government approvals and recruitment affecting the U.S. factory's production timeline [4]

Market Overview - The personal care products sector experienced a decline of 0.66% on September 15, with Runben Co., Ltd. leading the drop [1] - The Shanghai Composite Index closed at 3860.5, down 0.26%, while the Shenzhen Component Index closed at 13005.77, up 0.63% [1] Stock Performance - Key stocks in the personal care sector showed varied performance, with Jieya Co. rising by 3.95% to a closing price of 35.01 [1] - Other notable performers included Yiyi Co. with a 1.58% increase and Stable Medical with a 0.92% increase [1] - Conversely, Runben Co. fell by 2.62% to a closing price of 28.25, marking the largest decline in the sector [2] Trading Volume and Capital Flow - The personal care products sector saw a net outflow of 64.90 million yuan from institutional investors, while retail investors contributed a net inflow of 75.99 million yuan [2][3] - The trading volume for Jieya Co. reached 39,500 shares, with a transaction value of approximately 134 million yuan [1] Individual Stock Analysis - Jieya Co. had a net inflow of 6.89 million yuan from institutional investors, while retail investors showed a net outflow of 1.39 million yuan [3] - Stable Medical also experienced a net inflow of 22.62 million yuan from institutional investors, despite a net outflow from retail investors [3] - Runben Co. faced a significant net outflow of 9.70 million yuan from institutional investors, indicating weaker institutional interest [3]

Market Overview - The personal care products sector experienced a decline of 1.1% on September 12, with Baiya Co., Ltd. leading the drop [1] - The Shanghai Composite Index closed at 3883.69, up 0.22%, while the Shenzhen Component Index closed at 12996.38, up 0.13% [1] Stock Performance - Key stocks in the personal care sector showed varied performance, with Jeya Co., Ltd. increasing by 5.01% to a closing price of 34.18 [1] - Other notable movements include: - Yiyi Co., Ltd. up 0.53% to 28.40 - Runben Co., Ltd. down 0.41% to 28.82 - Reliable Co., Ltd. down 0.64% to 13.87 [1][2] Trading Volume and Value - The trading volume and value for selected stocks are as follows: - Jeya Co., Ltd.: 36,300 shares, 123 million yuan - Yiyi Co., Ltd.: 60,500 shares, 175 million yuan - Runben Co., Ltd.: 15,900 shares, 46.01 million yuan [1] Capital Flow Analysis - The personal care products sector saw a net outflow of 24.69 million yuan from institutional investors and 8.31 million yuan from speculative funds, while retail investors had a net inflow of 33 million yuan [2] - Detailed capital flow for selected stocks indicates: - Zhongshun Jierou: 12.26 million yuan net inflow from institutions - Yiyi Co., Ltd.: 6.18 million yuan net inflow from institutions [3] Summary of Individual Stocks - Zhongshun Jierou had a net institutional inflow of 12.26 million yuan, but a net outflow from speculative and retail investors [3] - Reliable Co., Ltd. showed mixed results with a small net inflow from speculative funds but a net outflow from retail investors [3] - Overall, the sector's performance reflects a cautious sentiment among institutional and speculative investors, while retail investors appear to be more active [2][3]

Market Overview - The personal care products sector increased by 0.76% on September 11, with Yanjiang Co., Ltd. leading the gains [1] - The Shanghai Composite Index closed at 3875.31, up 1.65%, while the Shenzhen Component Index closed at 12979.89, up 3.36% [1] Stock Performance - Yanjiang Co., Ltd. (300658) closed at 8.61, with a rise of 6.82% and a trading volume of 412,000 shares, amounting to a transaction value of 353 million yuan [1] - Yiyi Co., Ltd. (001206) closed at 28.25, up 4.28%, with a trading volume of 77,700 shares and a transaction value of 215 million yuan [1] - Beijia Co., Ltd. (603059) closed at 32.58, up 2.45%, with a trading volume of 62,400 shares and a transaction value of 203 million yuan [1] - Other notable performances include Reliable Co., Ltd. (301009) at 13.96 (+1.82%), and Zhongshun Jiesang (002511) at 8.58 (+1.06%) [1] Capital Flow Analysis - The personal care products sector experienced a net outflow of 43.97 million yuan from institutional investors and 22.16 million yuan from speculative funds, while retail investors saw a net inflow of 66.14 million yuan [2] - The detailed capital flow for individual stocks shows that Yiyi Co., Ltd. had a net inflow of 11.10 million yuan from institutional investors, while Reliable Co., Ltd. had a net inflow of 4.75 million yuan [3] - Conversely, companies like Two-Sided Needle (600249) and Dengkang Oral Care (001328) experienced significant net outflows from institutional and speculative funds [3]

Investment Rating - The report maintains an "Accumulate" rating for the company [1][3]. Core Views - The company is a leading manufacturer of wet wipes in China, with over 20 years of experience, focusing on research, production, and sales of various wet wipe products [2][11]. - The company is expected to reach an inflection point in performance, driven by international market expansion and a recent stock incentive plan that reflects growth confidence [2][3]. - The company has a strong international customer base, including well-known brands such as Woolworths, Kimberly-Clark, Johnson & Johnson, and L'Oréal, which provides a stable order flow and high-margin opportunities [2][3][49]. Summary by Sections Company Overview - The company specializes in wet wipes, offering over 60 products across six major categories, including baby wipes, adult functional wipes, antibacterial wipes, household cleaning wipes, medical care wipes, and pet cleaning wipes [2][11]. - The company has adopted an ODM/OEM model to produce wet wipes for global brands, enhancing its market presence [2][11]. Industry Analysis - The global wet wipes market is projected to grow steadily, with a market size of approximately $18.4 billion (about 132.1 billion RMB) in 2024, and a compound annual growth rate (CAGR) of 4.6% from 2024 to 2029 [41]. - The North American and European markets dominate the global wet wipes consumption, accounting for 64.5% of the total market [41]. Company Analysis - The company has a high customer concentration, primarily serving international clients, which contributes to stable cash flow and reduces risks [49][57]. - The company has a competitive edge in securing orders due to long-term relationships with international clients and advanced production technology [58][64]. - The company is expanding its production capacity, with a new facility in the United States expected to be operational by 2026, which will significantly enhance its market share in North America [72]. Financial Forecast - The company anticipates a recovery in revenue, projecting a net profit of 0.8 billion RMB in 2025, increasing to 1.4 billion RMB by 2027, with corresponding price-to-earnings (P/E) ratios of 50, 38, and 29 [3][76]. - The revenue for 2025 is estimated at 727.5 million RMB, reflecting a growth rate of 32.89% compared to 2024 [4][75].